BioVie’s drug candidate NE-3107 is a new molecule with a unique mechanism of action that is believed to have the potential to interrupt both inflammation and insulin resistance in the brain
I've become more suspicious about drugs that try to inhibit or interrupt natural processes. Also, the side effects appear to be ominous.